Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: www.fda.gov/media/131878/download. 2021.06.005.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 17, 2021

Parallel has ongoing operations in five medical and adult-use markets under the retail brands of Surterra Wellness in Florida ; goodblend in Texas and in Pennsylvania ; New England Treatment Access (NETA) in Massachusetts , and a joint venture with Cookie’s retail brand in Nevada. Find more information at www.liveparallel.com.

Retail 52

Retail Concentrates Safety Treatment 52

Cannabis Law Report

NOVEMBER 24, 2019

Severe treatment-resistant epilepsy. Consider nabilone as an add-on treatment for adults (18 years and over) with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics. 1.4 Severe treatment-resistant epilepsy. Recommendations for research. Rationale and impact. Recommendations.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

MMJ Recs

SEPTEMBER 25, 2023

With a growing recognition of its potential therapeutic benefits, Iowa has established a medical marijuana program to provide eligible patients with access to cannabis-based treatments. The Iowa medical marijuana program represents a significant step forward in providing patients with alternative treatment options.

Law 52

Law Chronic Pain Treatment Programs 52

PrestoDoctor

APRIL 19, 2019

A physician may certify a patient if they feel that the use of medical marijuana will be an appropriate treatment for that patient’s particular medical condition. card approved for identification purposes by the Oklahoma Department of Public Safety. passport (or other photo I.D. issued by the U.S government) A tribal I.D.

Marijuana 40

Marijuana Conditions Patients Programs 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

DECEMBER 9, 2021

The study involved 100 treatment-resistant patients and were randomized to psilocybin or the nicotine patch, each receiving the same cognitive-behavioral therapy. At 12 months, 59% of the patients who received the psilocybin treatment remained abstinent, while only 28% of those who received the nicotine patch remained abstinent.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Greencamp

SEPTEMBER 12, 2018

When it comes to medical treatment, the most common options are SSRIs and antipsychotics. In a 2015 statement, the Canadian Pediatric Society said that “there is little data to support either the efficacy or safety of cannabis use for any indications in children.”. Is it ethical to treat children with medical cannabis?

Strains 76

Strains Research and Development Marijuana Therapy 76

Cannabis Law Report

JULY 15, 2022

But bottlenecks remain to doctors prescribing the controversial treatment. “Not just the perimeter security, but also the safety and security onsite is paramount.” “Everything will be quality tested onsite. We will then validate it off site at the University of the Sunshine Coast,” Mr Benjamin said.

Medicine 52

Medicine Patients Media Supply Chain 52

CannaMD

FEBRUARY 18, 2020

However, the bills do include stipulations for jobs that are more safety sensitive, where marijuana use could pose a safety risk to the individual or someone else. If you’d like to learn more about medical marijuana you can download our free e-book. Find Out if You Qualify. You may be eligible for medical marijuana! Get Started.

Marijuana 66

Marijuana Medicine Policy Safety 66

Cannabis Law Report

SEPTEMBER 22, 2019

Usage of over-the-counter pain relievers and sleep aids, as well as prescription pain relievers and anti-anxiety medications dropped” For more detailed findings from this report, access the corresponding downloadable whitepaper here. Americans for Safe Access — Review the Five Key Takeaways from Report.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Sam’s large social media outlets and podcast (over 1 million downloads per episode) frequently discuss psychedelics, which has opened the conversation to millions of new listeners and readers. Sam Harris. Making Sense Podcast. in/peterattiamd/ [link]. Duncan Trussell.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

AUGUST 12, 2019

Licensed Medical Marijuana Treatment Centers authorized to dispense products in any form or delivery route to qualified patients currently include twelve companies called dispensaries. DOWNLOAD » OMMU guide to help active MMJ patients view recommendation. Almut Winterstein, Ph.D., LEARN » THC. LEARN » CBD. CAPITAL » private. .

Marijuana 40

Marijuana Dispensary Programs Patients 40